Positive Report for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) from Morgans
In a report released today, Derek Jellinek from Morgans upgraded Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh to a Buy, with a price target of A$47.73.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Jellinek is a 2-star analyst with an average return of 1.1% and a 42.86% success rate.
In a report released today, TipRanks – OpenAI also reiterated a Buy rating on the stock with a A$42.00 price target.
Based on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$1.45 billion and a net profit of A$399.08 million. In comparison, last year the company earned a revenue of A$1.28 billion and had a net profit of A$344.62 million
Read More on AU:RMD:
